Scientist II Analytical Development and Services

Based in Toulouse France

Permanent position

Were excited to share this opportunity is part of the Sandoz acquisition of Just-Evotec Biologics in Toulouse. Through this opportunity you will impact the lives of hundreds of millions of people through bold ideas supported by an inclusive agile company culture. Join us to help make healthcare fairer and faster help us to pioneer access to medicine! Click to learn more.

What Youll Do:

• Development & Qualification of analytical methods (HPLC/CE related). SME in CE based method is plus

• Regular analysis and in-process support to the process development team.

• Transfer of analytical methods to quality control (QC) or external laboratories.

• Work with team members to support process development teams with high-throughput analytical procedures.

• Utilize chromatography data systems and informatics platforms to analyze and distribute analytical results.

Who You Are:

• Holder of a Masters degree in biotechnology bioprocess engineering pharmaceutical sciences biochemistry or related filed with 5 years of relevant experience or Ph.D. holder with 0-1 years of relevant experience in pharmaceutical and or/biotechnology industry.

• Able to prove practical experience in analytical techniques like H/UPLC (SEC RP HILIC IEX) CE (CE-SDS icIEF) and Protein concentration determination by A280 method but also in statistical analysis

• Experienced in method development method qualification/validation and method transfer to external or quality control (QC) laboratory.

• Able to prove working experience in GLP or GxP laboratories

• Experienced with large molecule and protein characterization (a must).

• Willing to work in a fast collaborative team-oriented environment

• Fluent in English (mandatory). Confortable with French would be an added value.

Why Sandoz

Generic and Biosimilar medicines are the backbone of the global medicines industry. Sandoz a leader in thissectorprovidedmore than900 million patient treatmentsacross 100 countries in 2024and while we are proud of this achievement wehave an ambition todo more!

With investments in new development capabilities state-of-the-art production sites new acquisitions and partnerships we have the opportunity to shape the future of Sandoz and help more patients gain access to low-cost high-quality medicines sustainably.

The future is ours to shape!

FR : Dans le cadre de sa politique Diversité Evotec étudie à compétences égales toutes les candidatures dont celles des personnes en situation de handicap.

ENG : In the frame of our Diversity policy Evotec considers with equal competences all applications including people with disabilities.